Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Nicholas Cost

Concepts (372)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Neoplasms
55
2024
333
16.810
 Why?
Wilms Tumor
29
2024
68
11.080
 Why?
Testicular Neoplasms
23
2023
95
10.260
 Why?
Neoplasms, Germ Cell and Embryonal
14
2023
60
6.800
 Why?
Nephrectomy
31
2023
162
6.650
 Why?
Carcinoma, Renal Cell
17
2023
174
4.370
 Why?
Lymph Node Excision
12
2023
158
3.660
 Why?
Rhabdoid Tumor
5
2023
80
3.100
 Why?
Lymph Nodes
9
2023
443
2.930
 Why?
Neoplasm Staging
25
2023
1221
2.780
 Why?
Medical Oncology
7
2023
229
2.520
 Why?
Orchiectomy
8
2023
57
2.250
 Why?
Child
81
2024
19033
2.230
 Why?
Laparoscopy
11
2018
417
2.190
 Why?
Child, Preschool
60
2023
9448
2.180
 Why?
Rhabdomyosarcoma
5
2022
56
2.080
 Why?
Hydronephrosis
6
2019
30
2.060
 Why?
Adolescent
64
2023
18364
1.980
 Why?
Lymphatic Metastasis
12
2022
306
1.850
 Why?
Urologic Surgical Procedures
8
2019
94
1.830
 Why?
Infant
50
2023
8254
1.820
 Why?
Urologists
3
2017
18
1.780
 Why?
Urology
7
2023
48
1.730
 Why?
Urologic Neoplasms
4
2017
25
1.700
 Why?
Urinary Bladder
4
2022
180
1.630
 Why?
Kidney Pelvis
6
2015
20
1.590
 Why?
Adrenal Gland Neoplasms
3
2022
81
1.570
 Why?
Robotics
6
2015
83
1.560
 Why?
Male
94
2023
57476
1.560
 Why?
Humans
137
2024
118257
1.530
 Why?
Urinary Bladder Neoplasms
4
2021
211
1.410
 Why?
Lower Urinary Tract Symptoms
2
2021
47
1.390
 Why?
Organ Sparing Treatments
4
2023
31
1.340
 Why?
Doxorubicin
2
2021
301
1.340
 Why?
Ureteral Obstruction
5
2015
59
1.250
 Why?
Kidney
9
2023
1351
1.240
 Why?
Urodynamics
3
2019
31
1.230
 Why?
Urinary Bladder Diseases
2
2019
20
1.230
 Why?
Pediatrics
5
2019
980
1.210
 Why?
Prognosis
18
2023
3424
1.200
 Why?
Retrospective Studies
43
2023
12929
1.180
 Why?
Tumor Burden
6
2019
275
1.120
 Why?
Young Adult
31
2023
10731
1.090
 Why?
Female
71
2023
61262
1.060
 Why?
Kidney Diseases, Cystic
3
2021
20
1.040
 Why?
Rhabdomyosarcoma, Embryonal
2
2022
17
1.030
 Why?
Nephrons
9
2023
24
1.010
 Why?
Vincristine
2
2022
99
0.990
 Why?
Urinary Tract
2
2023
40
0.990
 Why?
Ribonuclease III
3
2021
33
0.970
 Why?
Practice Patterns, Physicians'
5
2019
1197
0.960
 Why?
Mixed Tumor, Malignant
1
2023
4
0.950
 Why?
DEAD-box RNA Helicases
3
2021
56
0.950
 Why?
Sertoli-Leydig Cell Tumor
3
2021
8
0.930
 Why?
Biopsy
5
2019
1078
0.920
 Why?
Hypospadias
4
2011
26
0.910
 Why?
Seminoma
3
2021
17
0.900
 Why?
Sarcoma, Clear Cell
2
2023
6
0.890
 Why?
Urologic Surgical Procedures, Male
4
2018
27
0.870
 Why?
Sarcoma
2
2022
137
0.860
 Why?
Spermatic Cord Torsion
2
2013
4
0.860
 Why?
Leydig Cell Tumor
3
2021
8
0.860
 Why?
Disease-Free Survival
7
2022
649
0.830
 Why?
Paraganglioma
1
2022
48
0.820
 Why?
Cryptorchidism
2
2019
12
0.820
 Why?
Age Factors
12
2019
2990
0.800
 Why?
Pulmonary Blastoma
1
2021
7
0.790
 Why?
Tomography, X-Ray Computed
9
2021
2433
0.790
 Why?
Peripheral Nervous System Diseases
1
2022
122
0.780
 Why?
Pheochromocytoma
2
2019
54
0.770
 Why?
Infant, Newborn
11
2023
5230
0.760
 Why?
Surgeons
3
2023
242
0.760
 Why?
Neoplasms, Muscle Tissue
1
2019
4
0.720
 Why?
Sex Cord-Gonadal Stromal Tumors
2
2017
5
0.710
 Why?
Cystectomy
1
2019
32
0.700
 Why?
Neoplasm Invasiveness
7
2017
460
0.700
 Why?
Smooth Muscle Myosins
1
2019
8
0.700
 Why?
Molecular Targeted Therapy
2
2013
355
0.690
 Why?
Muscle Relaxation
1
2019
32
0.690
 Why?
Myosin Light Chains
1
2019
35
0.690
 Why?
Diagnostic Imaging
3
2022
294
0.670
 Why?
Neoadjuvant Therapy
4
2021
333
0.670
 Why?
Treatment Outcome
25
2022
9319
0.660
 Why?
Antibiotics, Antineoplastic
1
2019
114
0.660
 Why?
Radiotherapy
1
2019
187
0.650
 Why?
Pregnancy Complications, Neoplastic
1
2018
51
0.650
 Why?
Specimen Handling
1
2019
163
0.650
 Why?
Catheterization
1
2019
164
0.650
 Why?
von Hippel-Lindau Disease
1
2018
12
0.640
 Why?
Testicular Diseases
1
2018
6
0.640
 Why?
Health Care Surveys
2
2017
544
0.630
 Why?
Calculi
1
2018
14
0.630
 Why?
Neoplasm Recurrence, Local
6
2019
895
0.630
 Why?
Tumor Suppressor Protein p53
2
2012
454
0.620
 Why?
Conservative Treatment
1
2018
30
0.620
 Why?
Orchiopexy
3
2019
5
0.620
 Why?
Cancer Survivors
1
2021
201
0.610
 Why?
Critical Pathways
1
2018
79
0.600
 Why?
Radiation Exposure
1
2017
44
0.600
 Why?
Kaplan-Meier Estimate
6
2019
840
0.600
 Why?
Risk Assessment
10
2018
3043
0.590
 Why?
Cytodiagnosis
1
2017
27
0.590
 Why?
Frozen Sections
1
2017
24
0.590
 Why?
Surveys and Questionnaires
3
2018
4684
0.590
 Why?
Kidney Medulla
1
2016
32
0.590
 Why?
Surgical Oncology
1
2016
14
0.580
 Why?
Lung Neoplasms
3
2021
2216
0.580
 Why?
Angiomyolipoma
1
2016
18
0.580
 Why?
Postoperative Care
1
2018
237
0.570
 Why?
Teratoma
2
2017
92
0.570
 Why?
Robotic Surgical Procedures
2
2015
89
0.570
 Why?
Tuberous Sclerosis
1
2016
38
0.560
 Why?
Muscle Contraction
1
2019
413
0.560
 Why?
Neoplasms
4
2023
2160
0.550
 Why?
Granuloma, Plasma Cell
1
2015
11
0.550
 Why?
Antineoplastic Combined Chemotherapy Protocols
4
2020
1385
0.540
 Why?
Adult
22
2020
31325
0.540
 Why?
Glomerular Filtration Rate
4
2018
681
0.530
 Why?
Survival Analysis
5
2019
1262
0.520
 Why?
Pediatricians
1
2016
120
0.520
 Why?
Adenoma
1
2016
191
0.510
 Why?
Neurofibromatosis 1
2
2019
37
0.500
 Why?
Pelvic Neoplasms
2
2013
20
0.490
 Why?
Cause of Death
1
2016
379
0.490
 Why?
Prostatic Neoplasms
2
2019
939
0.490
 Why?
Ovarian Neoplasms
3
2021
420
0.480
 Why?
Databases, Factual
5
2019
1196
0.480
 Why?
Polymorphism, Single Nucleotide
2
2012
2057
0.470
 Why?
Hypertension
1
2022
1199
0.470
 Why?
Acute-Phase Proteins
1
2013
65
0.460
 Why?
Lipocalins
1
2013
38
0.460
 Why?
Societies, Medical
4
2018
701
0.460
 Why?
SEER Program
5
2019
205
0.450
 Why?
Ultrasonography
5
2019
714
0.450
 Why?
Radiation Protection
1
2013
36
0.450
 Why?
Neoplasms, Radiation-Induced
1
2013
65
0.440
 Why?
Patient Education as Topic
1
2018
696
0.440
 Why?
Platelet Aggregation Inhibitors
1
2016
395
0.440
 Why?
Fertility Preservation
2
2023
47
0.430
 Why?
Biopsy, Needle
1
2013
188
0.430
 Why?
Multimodal Imaging
1
2013
100
0.430
 Why?
Retroperitoneal Space
1
2012
15
0.420
 Why?
Glucose Transporter Type 1
1
2012
42
0.420
 Why?
Neoplasm Metastasis
5
2019
541
0.410
 Why?
Incidence
7
2019
2413
0.410
 Why?
Follow-Up Studies
11
2019
4574
0.400
 Why?
Survival Rate
6
2024
1716
0.400
 Why?
United States
12
2021
12491
0.400
 Why?
Primary Prevention
1
2013
183
0.400
 Why?
Codon
1
2011
88
0.390
 Why?
Multivariate Analysis
5
2018
1469
0.390
 Why?
Positron-Emission Tomography
1
2013
298
0.390
 Why?
Proline
1
2011
71
0.390
 Why?
Seasons
1
2013
461
0.380
 Why?
Vena Cava, Inferior
1
2011
55
0.380
 Why?
Combined Modality Therapy
4
2023
1163
0.380
 Why?
Suburethral Slings
1
2010
5
0.370
 Why?
Temperature
1
2013
621
0.370
 Why?
Arginine
1
2011
247
0.370
 Why?
Breast Neoplasms
1
2022
1957
0.360
 Why?
Hernia, Ventral
1
2010
19
0.360
 Why?
Urinary Bladder, Neurogenic
1
2010
32
0.360
 Why?
Urinary Incontinence
1
2010
61
0.360
 Why?
Prospective Studies
8
2021
6443
0.350
 Why?
Proto-Oncogene Proteins
1
2013
618
0.350
 Why?
Ureter
4
2014
32
0.350
 Why?
Mouth Mucosa
1
2009
81
0.350
 Why?
Skin Transplantation
1
2009
58
0.350
 Why?
Attitude of Health Personnel
1
2016
990
0.350
 Why?
Campomelic Dysplasia
1
2009
2
0.350
 Why?
Dysgerminoma
1
2009
3
0.350
 Why?
Recovery of Function
1
2013
603
0.340
 Why?
Urolithiasis
1
2009
8
0.340
 Why?
Brachytherapy
2
2021
102
0.340
 Why?
Urethra
2
2011
58
0.340
 Why?
Angiogenesis Inhibitors
1
2011
218
0.340
 Why?
Bone Neoplasms
1
2011
198
0.340
 Why?
Clitoris
1
2009
9
0.340
 Why?
Venous Thrombosis
1
2011
145
0.340
 Why?
SOX9 Transcription Factor
1
2009
24
0.340
 Why?
Acute Kidney Injury
1
2015
705
0.330
 Why?
Aged
11
2021
19594
0.330
 Why?
Surgical Flaps
1
2009
118
0.320
 Why?
Time Factors
8
2019
6368
0.320
 Why?
Middle Aged
12
2021
27511
0.300
 Why?
Risk Factors
8
2018
8958
0.300
 Why?
Health Promotion
1
2013
685
0.290
 Why?
Calcinosis
1
2009
282
0.280
 Why?
Ureterocele
2
2016
7
0.270
 Why?
Vesico-Ureteral Reflux
2
2016
21
0.260
 Why?
Mitotic Index
2
2015
27
0.260
 Why?
Protein Kinase Inhibitors
1
2011
808
0.260
 Why?
Hypertrophy
2
2019
121
0.250
 Why?
Kidney Diseases
1
2009
439
0.250
 Why?
Chemotherapy, Adjuvant
4
2013
360
0.240
 Why?
Gonadal Dysgenesis
1
2023
9
0.230
 Why?
Minimally Invasive Surgical Procedures
3
2014
158
0.230
 Why?
Germ-Line Mutation
2
2021
134
0.220
 Why?
Pubic Bone
1
2022
4
0.220
 Why?
Algorithms
1
2009
1522
0.210
 Why?
Sex Factors
2
2017
1765
0.210
 Why?
Urination
1
2022
39
0.210
 Why?
Infertility
1
2022
45
0.210
 Why?
Sertoli Cell Tumor
1
2021
2
0.200
 Why?
Retroperitoneal Neoplasms
1
2021
23
0.200
 Why?
Testosterone
2
2015
350
0.200
 Why?
Sentinel Lymph Node Biopsy
1
2022
118
0.200
 Why?
Reoperation
3
2014
557
0.200
 Why?
Aniridia
1
2020
5
0.200
 Why?
Positron Emission Tomography Computed Tomography
2
2019
71
0.200
 Why?
Diagnosis, Differential
3
2019
1379
0.190
 Why?
PAX6 Transcription Factor
1
2020
23
0.190
 Why?
Neoplastic Syndromes, Hereditary
1
2021
29
0.190
 Why?
Codon, Nonsense
1
2020
38
0.190
 Why?
Interleukin-2
1
2022
416
0.190
 Why?
Eye Proteins
1
2020
77
0.190
 Why?
Pneumothorax
1
2021
48
0.190
 Why?
Syndrome
1
2021
343
0.180
 Why?
Penile Neoplasms
1
2019
7
0.180
 Why?
Priapism
1
2019
9
0.180
 Why?
Patient Selection
3
2013
670
0.180
 Why?
Genetic Predisposition to Disease
3
2021
2262
0.180
 Why?
Chemoradiotherapy, Adjuvant
1
2019
42
0.180
 Why?
Proportional Hazards Models
3
2011
1124
0.180
 Why?
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits
1
2019
10
0.170
 Why?
Large-Conductance Calcium-Activated Potassium Channel beta Subunits
1
2019
9
0.170
 Why?
Myosin-Light-Chain Kinase
1
2019
26
0.170
 Why?
Decision Trees
1
2019
83
0.170
 Why?
Computers
1
2019
64
0.170
 Why?
Puberty, Precocious
1
2019
14
0.170
 Why?
Dermatofibrosarcoma
1
2018
9
0.170
 Why?
Genetic Testing
2
2019
388
0.170
 Why?
Hospitals
1
2023
600
0.170
 Why?
Genotype
2
2016
1870
0.170
 Why?
Aged, 80 and over
4
2019
6541
0.170
 Why?
Diagnostic Errors
1
2019
162
0.160
 Why?
Self-Examination
1
2018
1
0.160
 Why?
Chemoradiotherapy
1
2019
199
0.160
 Why?
Tertiary Care Centers
1
2019
119
0.160
 Why?
Proton Therapy
1
2018
10
0.160
 Why?
Mutation
1
2009
3435
0.160
 Why?
General Surgery
1
2019
138
0.160
 Why?
Radiotherapy, Adjuvant
1
2018
189
0.150
 Why?
Preoperative Period
1
2018
109
0.150
 Why?
Feasibility Studies
2
2018
746
0.150
 Why?
Carcinoma, Medullary
1
2017
14
0.150
 Why?
Asymptomatic Diseases
1
2018
81
0.150
 Why?
Ultrasonography, Doppler
1
2018
104
0.150
 Why?
Drug Utilization
1
2018
169
0.150
 Why?
Unnecessary Procedures
1
2017
45
0.150
 Why?
Testis
1
2018
144
0.150
 Why?
Analysis of Variance
2
2017
1288
0.150
 Why?
Europe
1
2018
355
0.150
 Why?
Intraoperative Period
1
2017
55
0.150
 Why?
Postoperative Complications
4
2023
2230
0.150
 Why?
Fellowships and Scholarships
1
2019
250
0.140
 Why?
Logistic Models
3
2018
1896
0.140
 Why?
Pregnancy Outcome
1
2018
349
0.140
 Why?
Mice, Inbred BALB C
1
2019
1202
0.140
 Why?
Feminization
1
2015
6
0.140
 Why?
North America
1
2016
265
0.140
 Why?
Certification
1
2016
98
0.140
 Why?
Length of Stay
2
2018
1027
0.140
 Why?
Translocation, Genetic
2
2018
89
0.130
 Why?
Antineoplastic Agents
2
2018
1967
0.130
 Why?
Models, Statistical
1
2019
633
0.130
 Why?
Practice Guidelines as Topic
2
2020
1433
0.130
 Why?
Learning
1
2019
373
0.130
 Why?
History, 21st Century
1
2015
170
0.130
 Why?
Phosphorylation
1
2019
1622
0.130
 Why?
Registries
2
2019
1806
0.120
 Why?
Matched-Pair Analysis
1
2014
37
0.120
 Why?
Forecasting
1
2016
348
0.120
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2014
16
0.120
 Why?
Ureteral Calculi
1
2014
13
0.120
 Why?
Genitalia, Female
1
2014
40
0.120
 Why?
TRPM Cation Channels
1
2014
68
0.120
 Why?
Magnetic Resonance Imaging
3
2021
3169
0.120
 Why?
Kidney Function Tests
1
2014
163
0.120
 Why?
Lipocalin-2
1
2013
64
0.110
 Why?
Disease Management
1
2017
566
0.110
 Why?
Statistics, Nonparametric
1
2014
400
0.110
 Why?
Estrogens
1
2015
329
0.110
 Why?
Delivery of Health Care
1
2020
862
0.110
 Why?
Biomarkers, Tumor
2
2021
1056
0.110
 Why?
Cohort Studies
5
2016
5078
0.110
 Why?
Tissue Array Analysis
1
2012
52
0.110
 Why?
Blood Vessels
1
2014
187
0.110
 Why?
Spermatic Cord
1
2012
1
0.110
 Why?
Creatinine
1
2014
491
0.110
 Why?
Radiation Dosage
1
2013
147
0.100
 Why?
Fetal Diseases
1
2013
148
0.100
 Why?
Cross-Sectional Studies
2
2014
4522
0.100
 Why?
Monitoring, Physiologic
1
2014
268
0.100
 Why?
Immunoenzyme Techniques
1
2012
195
0.100
 Why?
Skin Neoplasms
1
2018
762
0.100
 Why?
Surgical Wound Dehiscence
1
2011
19
0.100
 Why?
Referral and Consultation
1
2016
644
0.100
 Why?
Autophagy
1
2014
312
0.100
 Why?
Carcinoma, Transitional Cell
1
2011
58
0.100
 Why?
Animals
4
2022
33152
0.100
 Why?
Clinical Competence
1
2017
950
0.090
 Why?
Thrombectomy
1
2011
59
0.090
 Why?
Bevacizumab
1
2011
123
0.090
 Why?
Texas
1
2011
186
0.090
 Why?
Sulfonamides
1
2014
444
0.090
 Why?
Compliance
1
2010
44
0.090
 Why?
Rectum
1
2011
155
0.090
 Why?
Pyrroles
1
2011
188
0.090
 Why?
Internship and Residency
1
2019
1005
0.090
 Why?
Chi-Square Distribution
1
2011
524
0.090
 Why?
Operative Time
3
2014
114
0.090
 Why?
Muscle, Smooth
1
2010
157
0.090
 Why?
Pilot Projects
1
2014
1405
0.090
 Why?
Penis
2
2019
37
0.090
 Why?
Polymerase Chain Reaction
1
2012
1004
0.080
 Why?
Drug Administration Schedule
1
2011
734
0.080
 Why?
Indoles
1
2011
311
0.080
 Why?
Alleles
1
2011
829
0.080
 Why?
Remission, Spontaneous
2
2021
37
0.080
 Why?
Radiography
1
2011
860
0.080
 Why?
MicroRNAs
1
2014
633
0.080
 Why?
Congenital Abnormalities
1
2008
72
0.080
 Why?
Predictive Value of Tests
1
2013
1857
0.080
 Why?
Biomarkers
2
2019
3568
0.080
 Why?
Mice
2
2022
15446
0.070
 Why?
Pregnancy
1
2018
5671
0.070
 Why?
Kidney Failure, Chronic
1
2012
514
0.070
 Why?
Case-Control Studies
1
2014
3156
0.070
 Why?
Antibodies, Monoclonal, Humanized
1
2011
665
0.070
 Why?
Severity of Illness Index
1
2014
2659
0.070
 Why?
Signal Transduction
1
2019
4688
0.070
 Why?
Cystoscopy
2
2016
16
0.070
 Why?
Anaplasia
1
2024
2
0.060
 Why?
Antibodies, Monoclonal
1
2011
1279
0.060
 Why?
Nephroureterectomy
1
2023
2
0.060
 Why?
Sexual Development
1
2023
20
0.060
 Why?
Gonads
1
2023
29
0.060
 Why?
Germany
1
2020
89
0.040
 Why?
Accreditation
1
2019
87
0.040
 Why?
Hyperplasia
1
2019
170
0.040
 Why?
Mohs Surgery
1
2018
25
0.040
 Why?
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
1
2018
26
0.040
 Why?
Perioperative Care
1
2019
131
0.040
 Why?
Mosaicism
1
2017
62
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2018
310
0.040
 Why?
Ureteroscopy
1
2016
16
0.040
 Why?
Monitoring, Intraoperative
1
2016
43
0.040
 Why?
Education, Medical, Graduate
1
2019
399
0.030
 Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2014
11
0.030
 Why?
Caveolin 1
1
2014
23
0.030
 Why?
Ureterostomy
1
2014
3
0.030
 Why?
Oncogenes
1
2014
110
0.030
 Why?
Neoplasm Transplantation
1
2014
245
0.030
 Why?
Cicatrix
1
2014
53
0.030
 Why?
Bone Marrow Neoplasms
1
2013
3
0.030
 Why?
Organ Size
1
2014
460
0.030
 Why?
Mice, Nude
1
2014
662
0.030
 Why?
RNA Interference
1
2014
459
0.030
 Why?
HEK293 Cells
1
2014
625
0.030
 Why?
Pain, Postoperative
1
2013
210
0.030
 Why?
Quality of Life
1
2022
2355
0.020
 Why?
Comparative Genomic Hybridization
1
2011
28
0.020
 Why?
Neoplasm Grading
1
2011
257
0.020
 Why?
Area Under Curve
1
2011
293
0.020
 Why?
Sensitivity and Specificity
1
2015
1787
0.020
 Why?
Gene Silencing
1
2011
177
0.020
 Why?
Preoperative Care
1
2012
332
0.020
 Why?
Dihydrolipoamide Dehydrogenase
1
2009
7
0.020
 Why?
Gene Expression Regulation, Neoplastic
1
2014
1161
0.020
 Why?
Cell Line, Tumor
1
2014
2837
0.020
 Why?
Analgesics, Opioid
1
2013
789
0.020
 Why?
Cost's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (372) concept(s)
_
Co-Authors Expand Description
See all (44) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)